Han, Y., Tu, W.W., Wen, Y.G., et al. (2013) Identification and Validation That Up-Expression of HOXA13 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Based on Immunohistochemistry. Medical Oncology, 30, 564-566.
https://doi.org/10.1007/s12032-013-0564-1

has been cited by the following article:

• TITLE: Research Progress of HOXA13/HOTTIP Gene and Digestive Tract Cancer

  AUTHORS: Meiling Fang, Yuantai Wan, Jinjun Li

  KEYWORDS: HOXA13, HOTTIP, Tumor of Digestive Tract

  JOURNAL NAME: Journal of Cancer Therapy, Vol.8 No.13, December 19, 2017

  ABSTRACT: The occurrence and development of digestive tract tumors are mainly caused by the interaction of genetic and environmental factors, multiple incentives, multiple genes involved, and multi-step regulation. With the development of gene sequencing technology, precise treatment of tumor era has arrived. Studies have shown that the HOXA13 gene in the homeobox gene is abnormally expressed in digestive system tumors. Studies have shown that HOXA13 may have a certain relationship with the occurrence, development and prognosis of the tumor, pending the diagnosis and treatment of digestive tract tumors with a new gene target.